12
May
11

Medical Marketing: Should the government protect against sharing confidential health records with marketers?

The Case of Sorrell v. IMS Health

Pharmaceutical companies, we love to hate them, don’t we? We want their research and their products, and yet we don’t we want them to have the information to help sell their products. At least this is true in Vermont.

On April 26, the Supreme Court heard oral arguments in the case of Sorrell v. IMS Health to determine whether Vermont’s prescription confidentiality law violates the free speech protections of the First Amendment. In 2007, Vermont passed Act 80, prohibiting prescription drug companies from obtaining patients’ personal information for marketing purposes without the prescribing physician’s consent. Pharmaceutical companies sued the state of Vermont arguing it was an unconstitutional restriction of their right to commercial speech.

Mr. Sorrell, the Vermont attorney general stated, “Vermont enacted its prescription confidentiality law with the idea that drug makers do not have an inherent right to a doctor’s identifiable prescription information for use in marketing because the data originated in highly government-regulated, nonpublic health care transactions.”

The basis of this case stems from how prescriptions are marketed to doctors. The process of marketing a new drug, as with any new products or service, typically begins with extensive market research. The research process in the pharmaceutical industry includes purchasing information collected from pharmacies pertaining to prescription data. This data provides marketers insight to their target audience, including the predominant type of services offered by physicians and the pharmaceutical brands physicians most frequently prescribed to patients. With this information, marketers define their market, present relevant drugs to physicians and maximize return on investment for marketing efforts.

Physicians and patients, not only the pharmaceutical companies, stand to benefit from this research. With an understanding of which physicians specialize in certain medical areas, pharmaceutical companies can make sure those physicians know what the latest treatment options are to better educate them on available drug choices for patients. Less money can be spent marketing to unnecessary audiences and, theoretically, more money can be spent on research and development.

And while this particular typed of research has immense payoffs for pharmaceutical companies, the practice of how this research is being collected has become progressively more litigious.

According to a New York Times article, “The case is being closely watched not only by drug makers and data collection firms, but also by health regulators, doctors and consumer advocates who say the decision will have profound implications for doctors’ control over their prescription histories, and for information privacy, medical decision-making and health care costs.”

If the ruling supports Act 80, pharmaceutical marketers will be faced with the massive dilemma of finding new methods to target specialized physicians and minimize marketing obstacles due to the lack of pertinent available data.

The Supreme Court’s decision will directly impact how physicians maintain prescription information, patient and physician privacy laws as well as the marketing of prescription drugs.

As we await the decision, share with us your thoughts on how the Court should rule. Share with us on Facebook at Weise Communications and follow @Weise_Ideas on Twitter.


8 Responses to “Medical Marketing: Should the government protect against sharing confidential health records with marketers?”


  1. April 1, 2013 at 1:34 am

    May I just say what a comfort to uncover an individual who actually understands what they are talking about on the net.

    You definitely realize how to bring a problem to light and make it important.
    A lot more people have to look at this and understand this side of the story.
    I can’t believe you are not more popular since you most certainly possess the gift.

  2. April 10, 2013 at 9:35 pm

    Hello mates, pleasant piece of writing and fastidious urging commented here, I am in fact enjoying by these.

  3. May 10, 2013 at 6:15 am

    I often wonder about the marginal changes the medical industry will go through with the up and coming reforms. I wonder how much the GOV will allow large companies (i.e. google) to monopolize on Medical Marketing with the use of private data. As far as I know in healthcare marketing, SEO Services for medical practices will be closely following these monopolies in potentia.

  4. April 18, 2014 at 7:42 am

    ” He also plans to work with federal authorities to regulate their sales over the internet. Those people who smoke a packet of cigarettes every day will save over seventy five percent when they switch to electronic cigarettes. The goal, stated by President Obama, is to curb smoking trends in younger generations, thereby preventing future generations of smokers.

  5. April 18, 2014 at 8:40 am

    Do you have a spam issue on this blog; I also am a blogger, and I was curious about your situation;
    many of us have created some nice procedures and we are looking to trade solutions
    with others, please shoot me an e-mail if interested.

  6. May 1, 2014 at 1:18 am

    I need to to thank you for this good read!! I certainly enjoyed every little bit of
    it. I have got you book-marked to look at new stuff you post…

  7. September 21, 2014 at 2:48 am

    It’s going to be end of mine day, however before finish I am reading this wonderful article to increase
    my experience.


Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


Share The Side Note

Facebook Twitter More...

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 1,100 other followers

Weise Twitter

Error: Twitter did not respond. Please wait a few minutes and refresh this page.

Archives


%d bloggers like this: